Two FTSE 100 dividend stocks I’d buy NOW

Plenty of FTSE 100 companies are offering very generous dividend yields at the moment. Here’s a look at two dividend stocks Edward Sheldon would buy now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As we begin November, stock market volatility is elevated. It’s not hard to see why. Covid-19, the US election, Brexit… there’s a lot of uncertainty right now.

Personally, I think this uncertainty is creating some fantastic buying opportunities for long-term investors, particularly in the dividend stock area. At present, plenty of well-established FTSE 100 companies are offering very generous yields. Here’s a look at two such dividend stocks I’d buy now.

A FTSE 100 dividend stock with a 5% yield

One FTSE 100 dividend stock I believe looks attractive at the moment is BAE Systems (LSE: BA). Its share price has been hammered recently. A month ago, it was near 500p. In the last week however, it has dipped below 400p.

There are a few reasons BAE’s share price has tanked over the last month. One is that investors are concerned that a Joe Biden US election win could result in lower US defence spending. Another is that there’s concern that government spending on Covid-19 will reduce the funds available to defence departments.

Both concerns are valid. However, I see the share price pullback as excessive. While Biden may not be as keen on defence as Trump, he’s made it clear that, if elected, he’ll push for continued military modernisation, including efforts to upgrade technology, strengthen cybersecurity, and develop drones and other autonomous vehicles.

And I don’t think defence spending in other countries is going to fall off a cliff. Given the high level of geopolitical tension worldwide, governments can’t afford to completely ignore defence.

It’s worth pointing out that only a few months ago, BAE’s chairman bought a ton of shares in the company at around the 480p mark. This suggests he thought there was value at that price. Today, the shares are much cheaper.

BAE is forecast to pay about 23p per share in dividends for this year. At the current share price, that equates to a yield of about 5.2%. The FTSE 100 stock’s forward-looking P/E ratio is about 10. All things considered, I see a lot of value here.

A dividend yield that’s hard to ignore

Another FTSE 100 dividend stock I’d snap up now is pharmaceutical giant GlaxoSmithKline (LSE: GSK). Like BAE, it’s underperformed recently. Over the last three months, its share price has fallen by about 10%. I think this share price weakness has created a great buying opportunity for dividend investors.

Glaxo’s third-quarter results, issued on 28 October, weren’t brilliant. For the period, turnover was down 3% at constant exchange rates while adjusted earnings per share were up just 1%. However, I’m convinced the long-term story here remains attractive.

In the long run, the company should benefit from both the world’s ageing population and increased healthcare spending in emerging economies. Meanwhile, by splitting up its business into two separate companies, it should create value for shareholders.

GSK is forecast to pay out 80p per share to investors this year. At the current share price, that equates to a dividend yield of 5.7%. In today’s low-interest-rate environment, I think that’s hard to ignore. The stock’s forward-looking P/E ratio is a very undemanding 11.7. Putting this all together, I see this FTSE 100 dividend stock as a buy right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in BAE Systems and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »